This is a Scotland news story, published by BBC, that relates primarily to Jeannie news.
For more Scotland news, you can click here:
more Scotland newsFor more Jeannie news, you can click here:
more Jeannie newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from BBC, you can click here:
more news from BBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Breast cancer patients. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest incurable breast cancer news, advanced breast cancer news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
JeannieBBC
•
73% Informative
Enhertu can give patients with incurable breast cancer an extra six months to live.
It is already available in 19 countries in Europe - including Scotland - but not in the rest of the UK .
NICE is the only organisation around the world to say no to the drug for this condition.
It says that it is too expensive for the NHS to fund.
Jeannie put us in touch with a group of about 20 women who are all in the same position as her.
They range from early 30s to mid 50s and all have advanced HER2-low breast cancer.
They have limited options to get Enhertu - some might be able to access it through private health insurance.
But Helen Knight , NICE’s director of medicines evaluation, argues that the severity modifier is working.
She says it has meant treatments like cystic fibrosis and hepatitis B are getting NHS funding.
VR Score
71
Informative language
66
Neutral language
83
Article tone
informal
Language
English
Language complexity
35
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
1
Affiliate links
no affiliate links